Amalgamated Bank Chimerix Inc Transaction History

Amalgamated Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$1.19 - $2.09 $2,177 - $3,824	-1,830 Reduced 15.15%	10,246 $13,000
Q3 2022 Nov 09, 2022	BUY	$1.81 - $2.76 $260 - $397	144 Added 1.21%	12,076 $23,000
Q2 2022 Aug 15, 2022	BUY	$1.34 - $5.34 $1,181 - $4,709	882 Added 7.98%	11,932 $25,000
Q1 2022 Jun 30, 2022	SELL	$4.58 - $6.8 $4,030 - $5,984	-880 Reduced 7.38%	11,050 $51,000
Q4 2021 Feb 15, 2022	SELL	$5.23 - $7.18 $1,814 - $2,491	-347 Reduced 2.83%	11,930 $77,000
Q3 2021 Oct 29, 2021	SELL	$5.94 - $8.75 $3,059 - $4,506	-515 Reduced 4.03%	12,277 $76,000
Q2 2021 Aug 16, 2021	BUY	$7.54 - $9.79 $96,451 - $125,233	12,792 New	12,792 $102,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.